• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

USP47通过去泛素化核糖体蛋白S2对p53进行负调控来促进肿瘤发生。

USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2.

作者信息

Cho Jinhong, Park Jinyoung, Shin Sang Chul, Jang Mihue, Kim Jae-Hong, Kim Eunice EunKyeong, Song Eun Joo

机构信息

Biomedical Research Institute, Korea Institute of Science and Technology, Hwarangno 14-gil 5, Seongbuk-gu, Seoul 02792, Korea.

Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, 5-1 Anam-dong, Sungbuk-gu, Seoul 02841, Korea.

出版信息

Cancers (Basel). 2020 May 1;12(5):1137. doi: 10.3390/cancers12051137.

DOI:10.3390/cancers12051137
PMID:32370049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7281321/
Abstract

p53 is activated in response to cellular stresses such as DNA damage, oxidative stress, and especially ribosomal stress. Although the regulations of p53 by E3 ligase and deubiquitinating enzymes (DUBs) have been described, the cellular roles of DUB associated with ribosomal stress have not been well studied. In this study, we report that Ubiquitin Specific Protease 47 (USP47) functions as an important regulator of p53. We show that ubiquitinated ribosomal protein S2 (RPS2) by Mouse double minute 2 homolog (MDM2) is deubiquitinated by USP47. USP47 inhibits the interaction between RPS2 and MDM2 thereby alleviating RPS2-mediated suppression of MDM2 under normal conditions. However, dissociation of USP47 leads to RPS2 binding to MDM2, which is required for the suppression of MDM2, consequently inducing up-regulation of the p53 level under ribosomal stress. Finally, we show that depletion of USP47 induces p53 and therefore inhibits cell proliferation, colony formation, and tumor progression in cancer cell lines and a mouse xenograft model. These findings suggest that USP47 could be a potential therapeutic target for cancer.

摘要

p53会在诸如DNA损伤、氧化应激尤其是核糖体应激等细胞应激反应中被激活。尽管已经描述了E3连接酶和去泛素化酶(DUBs)对p53的调控作用,但与核糖体应激相关的DUB的细胞作用尚未得到充分研究。在本研究中,我们报告泛素特异性蛋白酶47(USP47)作为p53的重要调节因子发挥作用。我们发现,小鼠双微体2同源物(MDM2)使核糖体蛋白S2(RPS2)泛素化,而USP47可使其去泛素化。在正常条件下,USP47抑制RPS2与MDM2之间的相互作用,从而减轻RPS2介导的对MDM2的抑制作用。然而,USP47的解离会导致RPS2与MDM2结合,这是抑制MDM2所必需的,从而在核糖体应激下诱导p53水平上调。最后,我们表明,USP47的缺失会诱导p53表达,因此会抑制癌细胞系和小鼠异种移植模型中的细胞增殖、集落形成及肿瘤进展。这些发现表明,USP47可能是癌症的一个潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/6769f0089087/cancers-12-01137-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/c1f85b70d6ea/cancers-12-01137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/b540665400d9/cancers-12-01137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/dcea71208518/cancers-12-01137-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/801544683f00/cancers-12-01137-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/b386eb8dc39b/cancers-12-01137-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/6769f0089087/cancers-12-01137-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/c1f85b70d6ea/cancers-12-01137-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/b540665400d9/cancers-12-01137-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/dcea71208518/cancers-12-01137-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/801544683f00/cancers-12-01137-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/b386eb8dc39b/cancers-12-01137-g007a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/907f/7281321/6769f0089087/cancers-12-01137-g008.jpg

相似文献

1
USP47 Promotes Tumorigenesis by Negative Regulation of p53 through Deubiquitinating Ribosomal Protein S2.USP47通过去泛素化核糖体蛋白S2对p53进行负调控来促进肿瘤发生。
Cancers (Basel). 2020 May 1;12(5):1137. doi: 10.3390/cancers12051137.
2
Ribosomal protein S2 interplays with MDM2 to induce p53.核糖体蛋白 S2 与 MDM2 相互作用诱导 p53。
Biochem Biophys Res Commun. 2020 Mar 5;523(2):542-547. doi: 10.1016/j.bbrc.2020.01.038. Epub 2020 Jan 10.
3
MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11.微小RNA-101-3p通过抑制USP47诱导的RPL11去泛素化来抑制癌细胞生长。
Cancers (Basel). 2022 Feb 15;14(4):964. doi: 10.3390/cancers14040964.
4
Reversible regulation of SATB1 ubiquitination by USP47 and SMURF2 mediates colon cancer cell proliferation and tumor progression.USP47 和 SMURF2 通过可逆调节 SATB1 的泛素化来介导结肠癌细胞的增殖和肿瘤进展。
Cancer Lett. 2019 Apr 28;448:40-51. doi: 10.1016/j.canlet.2019.01.039. Epub 2019 Feb 8.
5
Ubiquitin-specific peptidase 47 (USP47) regulates cutaneous oxidative injury through nicotinamide nucleotide transhydrogenase (NNT).泛素特异性肽酶 47(USP47)通过烟酰胺核苷酸转氢酶(NNT)调节皮肤氧化损伤。
Toxicol Appl Pharmacol. 2023 Dec 1;480:116734. doi: 10.1016/j.taap.2023.116734. Epub 2023 Nov 2.
6
Ribosomal protein S7 is both a regulator and a substrate of MDM2.核糖体蛋白S7既是MDM2的调节因子,也是其底物。
Mol Cell. 2009 Aug 14;35(3):316-26. doi: 10.1016/j.molcel.2009.07.014.
7
Mdm2 and tumorigenesis: evolving theories and unsolved mysteries.Mdm2与肿瘤发生:不断演变的理论及未解之谜
Genes Cancer. 2012 Mar;3(3-4):192-8. doi: 10.1177/1947601912457368.
8
The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis.RNA 结合蛋白 RALY 抑制 p53 活性并促进肺肿瘤发生。
Cell Rep. 2023 Apr 25;42(4):112288. doi: 10.1016/j.celrep.2023.112288. Epub 2023 Mar 22.
9
Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.核糖体蛋白L11对MDM2-p53通路的调控涉及泛素化后机制。
J Biol Chem. 2006 Aug 25;281(34):24304-13. doi: 10.1074/jbc.M602596200. Epub 2006 Jun 27.
10
The Regulation of Multiple p53 Stress Responses is Mediated through MDM2.多种p53应激反应的调节是通过MDM2介导的。
Genes Cancer. 2012 Mar;3(3-4):199-208. doi: 10.1177/1947601912454734.

引用本文的文献

1
USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer.USP47 缺失可调节前列腺癌肿瘤浸润免疫细胞并增强抗肿瘤免疫反应。
Cancer Immunol Immunother. 2024 Jun 4;73(8):143. doi: 10.1007/s00262-024-03730-5.
2
Comprehensive analysis of the role of ubiquitin-specific peptidases in colorectal cancer: A systematic review.泛素特异性肽酶在结直肠癌中的作用的综合分析:一项系统综述
World J Gastrointest Oncol. 2024 Jan 15;16(1):197-213. doi: 10.4251/wjgo.v16.i1.197.
3
Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer.

本文引用的文献

1
Ribosomal protein S2 interplays with MDM2 to induce p53.核糖体蛋白 S2 与 MDM2 相互作用诱导 p53。
Biochem Biophys Res Commun. 2020 Mar 5;523(2):542-547. doi: 10.1016/j.bbrc.2020.01.038. Epub 2020 Jan 10.
2
Deubiquitinating enzymes as cancer biomarkers: new therapeutic opportunities?去泛素化酶作为癌症生物标志物:新的治疗机会?
BMB Rep. 2019 Mar;52(3):181-189. doi: 10.5483/BMBRep.2019.52.3.048.
3
MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.MicroRNA-301b 通过靶向 CYLD 促进三阴性乳腺癌细胞增殖和抗凋亡。
微小RNA对非小细胞肺癌的调控作用及治疗潜力
Heliyon. 2023 Nov 14;9(11):e22080. doi: 10.1016/j.heliyon.2023.e22080. eCollection 2023 Nov.
4
ATXN3 deubiquitinates YAP1 to promote tumor growth.ATXN3通过去泛素化YAP1来促进肿瘤生长。
Am J Cancer Res. 2023 Sep 15;13(9):4222-4234. eCollection 2023.
5
Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms.泛素特异性蛋白酶 12(USP12)在疾病中的作用研究进展:从多功能角色到病理生理机制。
J Transl Med. 2023 Sep 26;21(1):665. doi: 10.1186/s12967-023-04540-6.
6
Structural and functional characterization of USP47 reveals a hot spot for inhibitor design.USP47 的结构与功能表征揭示了抑制剂设计的热点。
Commun Biol. 2023 Sep 22;6(1):970. doi: 10.1038/s42003-023-05345-5.
7
Upregulation of ubiquitin carboxy‑terminal hydrolase 47 (USP47) in papillary thyroid carcinoma ex vivo and reduction of tumor cell malignant behaviors after USP47 knockdown by stabilizing SATB1 expression in vitro.甲状腺乳头状癌中泛素羧基末端水解酶47(USP47)的体外上调以及通过体外稳定SATB1表达在USP47敲低后肿瘤细胞恶性行为的降低。
Oncol Lett. 2023 Jul 17;26(3):370. doi: 10.3892/ol.2023.13956. eCollection 2023 Sep.
8
Ubiquitin-proteasome system as a target for anticancer treatment-an update.泛素-蛋白酶体系统作为抗癌治疗的靶点——更新。
Arch Pharm Res. 2023 Jul;46(7):573-597. doi: 10.1007/s12272-023-01455-0. Epub 2023 Aug 5.
9
Mapping the tumor microenvironment in clear cell renal carcinoma by single-cell transcriptome analysis.通过单细胞转录组分析绘制透明细胞肾细胞癌的肿瘤微环境
Front Genet. 2023 Jul 18;14:1207233. doi: 10.3389/fgene.2023.1207233. eCollection 2023.
10
Construction and Verification of an RNA-Binding Protein-Associated Prognostic Model for Gliomas.一种用于胶质瘤的RNA结合蛋白相关预后模型的构建与验证
Curr Med Sci. 2023 Feb;43(1):156-165. doi: 10.1007/s11596-022-2694-1. Epub 2023 Mar 3.
BMB Rep. 2018 Nov;51(11):602-607. doi: 10.5483/BMBRep.2018.51.11.168.
4
USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation.USP7 和 USP47 去泛素化酶调节 NLRP3 炎症小体的激活。
EMBO Rep. 2018 Oct;19(10). doi: 10.15252/embr.201744766. Epub 2018 Sep 11.
5
SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.SPIN1 通过阻断人癌症中的 uL18(通用大核糖体亚基蛋白 18)-MDM2-p53 通路促进肿瘤发生。
Elife. 2018 Mar 16;7:e31275. doi: 10.7554/eLife.31275.
6
USP35 regulates mitotic progression by modulating the stability of Aurora B.USP35 通过调节 Aurora B 的稳定性来调控有丝分裂进程。
Nat Commun. 2018 Feb 15;9(1):688. doi: 10.1038/s41467-018-03107-0.
7
Hypoxia induces epithelial-mesenchymal transition in colorectal cancer cells through ubiquitin-specific protease 47-mediated stabilization of Snail: A potential role of Sox9.缺氧通过泛素特异性蛋白酶 47 介导的 Snail 稳定诱导结直肠癌细胞上皮-间充质转化: Sox9 的潜在作用。
Sci Rep. 2017 Nov 21;7(1):15918. doi: 10.1038/s41598-017-15139-5.
8
USP7: Target Validation and Drug Discovery for Cancer Therapy.USP7:癌症治疗的靶点验证与药物发现
Med Chem. 2018;14(1):3-18. doi: 10.2174/1573406413666171020115539.
9
Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.基于结构的 USP7 非共价活性位点强效和选择性抑制剂的开发。
Cell Chem Biol. 2017 Dec 21;24(12):1490-1500.e11. doi: 10.1016/j.chembiol.2017.09.003. Epub 2017 Oct 19.
10
The USP7 Inhibitor P5091 Induces Cell Death in Ovarian Cancers with Different P53 Status.USP7抑制剂P5091可诱导不同P53状态的卵巢癌细胞死亡。
Cell Physiol Biochem. 2017;43(5):1755-1766. doi: 10.1159/000484062. Epub 2017 Oct 19.